GS-5745 Terminated Phase 2 Trials for Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02759562Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis